CapsoVision, Inc. (CV)
4.95
-0.43
(-7.99%)
USD |
NASDAQ |
Feb 24, 16:00
4.95
0.00 (0.00%)
After-Hours: 20:00
CapsoVision Research and Development Expense (Quarterly) : 6.09M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Abbott Laboratories | 721.00M |
| Accuray, Inc. | 10.65M |
| Alphatec Holdings, Inc. | 18.68M |
| Boston Scientific Corp. | 569.00M |
| Plus Therapeutics, Inc. | 2.436M |